Loading...
Emtricitabine
India Pharmaceutical Trade Intelligence
Who Supplies Emtricitabine to India from CANADA
India's emtricitabine imports from CANADA total $171.0K across 18 shipments from 9 foreign suppliers. PATHEON INC leads with $75.0K in import value; the top 5 suppliers together control 98.0% of this origin. Leading Indian buyers include JOHNSON & JOHNSON PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for emtricitabine — a diversified sourcing base with multiple active suppliers from CANADA.
Top foreign suppliers (CANADA) — Ranked by import value
PATHEON INC is the leading Emtricitabine supplier from CANADA to India, with import value of $75.0K across 2 shipments. The top 5 suppliers — PATHEON INC, APOTEX INC, CELLBIOASIS INC, NATCO PHARMA (CANADA)INC., JAMP PHARMA CORPORATION — collectively account for 98.0% of total import value from this origin.
Top foreign suppliers (CANADA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PATHEON INC | $75.0K | 2 | 43.8% |
| 2 | APOTEX INC | $51.5K | 5 | 30.1% |
| 3 | CELLBIOASIS INC | $17.4K | 1 | 10.2% |
| 4 | NATCO PHARMA (CANADA)INC. | $16.4K | 1 | 9.6% |
| 5 | JAMP PHARMA CORPORATION | $7.3K | 2 | 4.3% |
| 6 | M/S. DELUXE HEALTH GROUP INC. | $2.0K | 1 | 1.2% |
| 7 | globyz pharma | $1.0K | 4 | 0.6% |
| 8 | GLOBYZ PHARMA | $292 | 1 | 0.2% |
| 9 | GILEAD LA VERNE | $31 | 1 | 0.0% |
Showing top 9 of 9 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CANADA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | JOHNSON & JOHNSON PRIVATE LIMITED | $75.0K | 2 | 43.8% |
| 2 | APOTEX RESEARCH PRIVATE LIMITED | $51.5K | 5 | 30.1% |
| 3 | LAURUS LABS LIMITED | $22.0K | 6 | 12.9% |
| 4 | LUPIN LIMITED | $17.4K | 1 | 10.2% |
| 5 | JEEVAN SCIENTIFIC TECHNOLOGY LIMITED | $3.0K | 2 | 1.8% |
| 6 | NATCO PHARMA LIMITED | $2.0K | 1 | 1.2% |
| 7 | AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED | $31 | 1 | 0.0% |
Import Statistics
- Import Value
- $171.0K
- Shipments
- 18
- Foreign Suppliers
- 9
- Indian Buyers
- 7
- Avg. Shipment
- $9.5K
Other Emtricitabine Import Origins
Related Analysis
Frequently Asked Questions — Emtricitabine Imports from CANADA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Emtricitabine suppliers from CANADA to India?
The top Emtricitabine suppliers from CANADA to India include PATHEON INC, APOTEX INC, CELLBIOASIS INC. The leading supplier is PATHEON INC with import value of $75.0K USD across 2 shipments. India imported Emtricitabine worth $171.0K USD from CANADA in total across 18 shipments.
QHow much Emtricitabine does India import from CANADA?
India imported Emtricitabine worth $171.0K USD from CANADA across 18 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Emtricitabine from CANADA?
The main Indian buyers of Emtricitabine sourced from CANADA include JOHNSON & JOHNSON PRIVATE LIMITED, APOTEX RESEARCH PRIVATE LIMITED, LAURUS LABS LIMITED. The largest buyer is JOHNSON & JOHNSON PRIVATE LIMITED with $75.0K in imports across 2 shipments.
QWhat is the total value of Emtricitabine imports from CANADA to India?
The total value of Emtricitabine imports from CANADA to India is $171.0K USD, across 18 shipments and 9 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CANADA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Emtricitabine.
- 2.Supplier/Buyer Matching: 9 foreign suppliers from CANADA and 7 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $171.0K aggregated from 18 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
18 Verified Shipments
9 suppliers, 7 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists